← Back to All Stocks

Biodexa Pharmaceuticals Plc (BDRX) Analysis

Generated on: 2025-06-22 14:15:50 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$1.18
Predicted Price
$1.00
Expected Return
-13.09%
Confidence Score
0.83
RSI (14)
37.34
MACD
-0.11
Volume
1,722,100
Float Shares
22,018,676,243
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249

BDRX

Biodexa Pharmaceuticals Plc
-13.09%
Price: $1.18
Confidence: 0.83
News
Last updated: 2025-06-22 14:15:50

Technical Analysis

RSI: 37.34
MACD: -0.11
Technical Analysis Graph

Risk Analysis

Volatility
148.72%
Max Drawdown
-97.05%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
TipRanks - 2025-05-31 12:40
As of May 29, 2025, the Company had access to the following cash resources: Cash at bank $5.7M; Cash in escrow for eRapa Phase 3 program $4.4M; Undrawn CPRIT grant for eRapa Phase 3 program $11.9M; Debt $0.5M. The CPRIT grant, together with Company match means the eRapa Phase 3 program is substantially funded. Based on its latest projections, the Company has sufficient working capital to fund operations into the first quarter of 2026. Issued shares, total voting rights, market capitalization As

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.